Home

General Catalyst Partners VIII, L.P.

CIK 1758429 · last filed 2020-07-31

General Catalyst Partners VIII, L.P. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing, for LVGO, was dated Jul 31, 2020. Across all open-market trades the lifetime net is +$750.0M, making them a net buyer over the disclosed history. The firm reports its address in Cambridge, MA. 11 SEC filings were submitted jointly with General Catalyst Group Management Holdings GP, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

3

Lifetime Open-Market Net

$750.00M

Filer Profile

Reported Address
20 UNIVERSITY ROAD
4TH FLOOR
CAMBRIDGE, MA 02138
Phone
(617) 234-7000
State of Incorporation
DE
Related Filers
General Catalyst Group Management Holdings GP, LLC — 11 joint filings, latest 2020-11-03
General Catalyst Group Management, LLC — 11 joint filings, latest 2020-11-03
General Catalyst Group VIII, L.P. — 11 joint filings, latest 2020-11-03
General Catalyst Group VIII Supplemental, L.P. — 10 joint filings, latest 2020-11-03
General Catalyst GP VI, LLC — 8 joint filings, latest 2020-11-03
General Catalyst Partners VI, L.P. — 8 joint filings, latest 2020-11-03
KENNETH I CHENAULT — 2 joint filings, latest 2020-07-08
David P Fialkow — 2 joint filings, latest 2020-07-08
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Livongo Health, Inc. (LVGO) Delisted 10%+ Owner 971,064 — — $750.00M 3 2020-07-31

Recent Filings

3 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-07-31 Livongo Health, Inc. (LVGO) Delisted Other (J) −20,246,530 $0 EDGAR
2020-05-19 Livongo Health, Inc. (LVGO) Delisted Other (J) −20,000,000 $0 EDGAR
2019-07-31 Livongo Health, Inc. (LVGO) Delisted Mixed +196,223,080 $750.00M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.